लोड हो रहा है...
Bevacizumab in metastatic breast cancer: when may it be used?
Tumor angiogenesis, which is necessary for breast cancer growth, invasion and metastases, is regulated by pro-angiogenic factors such as vascular endothelial growth factor (VEGF). Bevacizumab is a recombinant humanized monoclonal antibody that targets VEGF. The addition of bevacizumab to chemotherap...
में बचाया:
| मुख्य लेखकों: | , , |
|---|---|
| स्वरूप: | Artigo |
| भाषा: | Inglês |
| प्रकाशित: |
SAGE Publishing
2011-03-01
|
| श्रृंखला: | Therapeutic Advances in Medical Oncology |
| ऑनलाइन पहुंच: | https://doi.org/10.1177/1758834010397627 |
| टैग : |
टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!
|